IL227651A0 - Pharmaceutical formulation for topical administration comprising b220 - Google Patents
Pharmaceutical formulation for topical administration comprising b220Info
- Publication number
- IL227651A0 IL227651A0 IL227651A IL22765113A IL227651A0 IL 227651 A0 IL227651 A0 IL 227651A0 IL 227651 A IL227651 A IL 227651A IL 22765113 A IL22765113 A IL 22765113A IL 227651 A0 IL227651 A0 IL 227651A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical formulation
- topical administration
- topical
- administration
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161444275P | 2011-02-18 | 2011-02-18 | |
| EP20110154979 EP2489354A1 (en) | 2011-02-18 | 2011-02-18 | Pharmaceutical formulation of B220 for topical treatment of herpes |
| PCT/EP2012/052763 WO2012110631A1 (en) | 2011-02-18 | 2012-02-17 | Pharmaceutical formulation for topical administration comprising b220 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL227651A0 true IL227651A0 (en) | 2013-09-30 |
| IL227651A IL227651A (en) | 2017-02-28 |
Family
ID=43737812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL227651A IL227651A (en) | 2011-02-18 | 2013-07-25 | Pharmaceutical formulation for topical administration comprising b220 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9119852B2 (en) |
| EP (2) | EP2489354A1 (en) |
| JP (1) | JP6078006B2 (en) |
| KR (3) | KR20190100421A (en) |
| CN (2) | CN107982207A (en) |
| AU (1) | AU2012217011B2 (en) |
| BR (1) | BR112013020632B1 (en) |
| CA (1) | CA2826074C (en) |
| ES (1) | ES2856891T3 (en) |
| IL (1) | IL227651A (en) |
| MY (1) | MY166556A (en) |
| RU (1) | RU2608909C2 (en) |
| SG (1) | SG192809A1 (en) |
| UA (1) | UA111837C2 (en) |
| WO (1) | WO2012110631A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD884038S1 (en) | 2018-06-11 | 2020-05-12 | Samsung Electronics Co., Ltd. | Drawer for refrigerator |
| WO2020160537A1 (en) | 2019-02-01 | 2020-08-06 | University Of South Carolina | Bicyclic pyridine compositions and methods of using the same for cancer therapy |
| WO2022002898A1 (en) | 2020-06-29 | 2022-01-06 | Vironova Medical Ab | 6h-indolo(2,3-b)quinoxaline derivatives useful in therapy in particular in a virus infection |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8600260D0 (en) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | SUBSTITUTED INDOLOKINOXALINES |
| GB8926595D0 (en) | 1989-11-24 | 1990-01-17 | Surtech Int Ltd | Pharmaceutical compositions for use in the treatment herpes simplex virus infections |
| US5514667A (en) * | 1990-11-05 | 1996-05-07 | Arthropharm Pty. Limited | Method for topical treatment of herpes infections |
| ES2101850T3 (en) * | 1991-06-20 | 1997-07-16 | Viro Tex Corp | TOPICAL COMPOSITION THAT ENHANCES THE HEALING OF HERPES INJURIES. |
| TW438585B (en) * | 1995-02-06 | 2001-06-07 | Astra Ab | Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections |
| WO1999053912A1 (en) * | 1998-04-20 | 1999-10-28 | Torrey Pines Institute For Molecular Studies | Topical immunostimulation to induce langerhans cell migration |
| EP1236466B1 (en) * | 2001-02-28 | 2011-09-21 | Axiomedic Ltd. | Solid self-adhesive compositions for topical treatment of oral mucosal disorders |
| JP2004026819A (en) * | 2002-05-09 | 2004-01-29 | Yamanouchi Pharmaceut Co Ltd | Medicinal composition |
| SE527639C2 (en) * | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkyl-substituted indoloquinoxalins |
| SE529777C2 (en) | 2006-01-23 | 2007-11-20 | Vironova Ab | New compounds and their use |
| US20080081020A1 (en) * | 2006-10-03 | 2008-04-03 | Huang Yeong H | Color change surgical prep solution |
| US20110318298A1 (en) | 2008-10-14 | 2011-12-29 | Nippon Shokubai Co., Ltd. | Viral infection therapeutic drug containing polyalkyleneimine |
-
2011
- 2011-02-18 EP EP20110154979 patent/EP2489354A1/en not_active Withdrawn
-
2012
- 2012-02-17 RU RU2013142445A patent/RU2608909C2/en active
- 2012-02-17 UA UAA201309064A patent/UA111837C2/en unknown
- 2012-02-17 KR KR1020197023911A patent/KR20190100421A/en not_active Application Discontinuation
- 2012-02-17 KR KR20137024811A patent/KR20140025347A/en not_active Application Discontinuation
- 2012-02-17 EP EP12704419.6A patent/EP2675457B1/en active Active
- 2012-02-17 CN CN201711327271.8A patent/CN107982207A/en active Pending
- 2012-02-17 US US13/984,105 patent/US9119852B2/en not_active Expired - Fee Related
- 2012-02-17 JP JP2013553949A patent/JP6078006B2/en active Active
- 2012-02-17 CA CA2826074A patent/CA2826074C/en active Active
- 2012-02-17 WO PCT/EP2012/052763 patent/WO2012110631A1/en active Application Filing
- 2012-02-17 SG SG2013062328A patent/SG192809A1/en unknown
- 2012-02-17 KR KR1020207021727A patent/KR20200091964A/en not_active Application Discontinuation
- 2012-02-17 MY MYPI2013003056A patent/MY166556A/en unknown
- 2012-02-17 BR BR112013020632-2A patent/BR112013020632B1/en not_active IP Right Cessation
- 2012-02-17 CN CN2012800091847A patent/CN103442713A/en active Pending
- 2012-02-17 AU AU2012217011A patent/AU2012217011B2/en not_active Ceased
- 2012-02-17 ES ES12704419T patent/ES2856891T3/en active Active
-
2013
- 2013-07-25 IL IL227651A patent/IL227651A/en active IP Right Grant
-
2015
- 2015-07-22 US US14/805,929 patent/US9789107B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MY166556A (en) | 2018-07-16 |
| AU2012217011A1 (en) | 2013-04-04 |
| CN107982207A (en) | 2018-05-04 |
| EP2675457B1 (en) | 2020-12-16 |
| BR112013020632A2 (en) | 2016-10-04 |
| EP2675457A1 (en) | 2013-12-25 |
| BR112013020632B1 (en) | 2021-09-28 |
| EP2489354A1 (en) | 2012-08-22 |
| UA111837C2 (en) | 2016-06-24 |
| US20150320746A1 (en) | 2015-11-12 |
| RU2013142445A (en) | 2015-03-27 |
| KR20190100421A (en) | 2019-08-28 |
| CA2826074A1 (en) | 2012-08-23 |
| US9119852B2 (en) | 2015-09-01 |
| CN103442713A (en) | 2013-12-11 |
| JP2014505716A (en) | 2014-03-06 |
| RU2608909C2 (en) | 2017-01-26 |
| BR112013020632A8 (en) | 2018-04-03 |
| KR20140025347A (en) | 2014-03-04 |
| SG192809A1 (en) | 2013-09-30 |
| JP6078006B2 (en) | 2017-02-08 |
| AU2012217011B2 (en) | 2015-02-05 |
| CA2826074C (en) | 2021-05-11 |
| WO2012110631A1 (en) | 2012-08-23 |
| NZ613313A (en) | 2015-06-26 |
| US9789107B2 (en) | 2017-10-17 |
| KR20200091964A (en) | 2020-07-31 |
| US20130310392A1 (en) | 2013-11-21 |
| IL227651A (en) | 2017-02-28 |
| ES2856891T3 (en) | 2021-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2560624T3 (en) | Therapeutic formulation for reduced drug side effects | |
| HRP20181896T1 (en) | Pharmaceutical formulations | |
| HK1204564A1 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
| HK1205462A1 (en) | Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative | |
| IL228465A0 (en) | Pharmaceutical formulation comprising inositol | |
| HK1206292A1 (en) | Medicament administration | |
| HK1205146A1 (en) | Pharmaceutical formulation | |
| AP3803A (en) | Pharmaceutical dosage form | |
| AP2015008208A0 (en) | Pharmaceutical administration forms comprising | |
| IL227651A0 (en) | Pharmaceutical formulation for topical administration comprising b220 | |
| GB201110632D0 (en) | Drug delivery formulations | |
| GB201316049D0 (en) | Excipient system for topical delivery of pharmaceutical agents | |
| ZA201502354B (en) | Pharmaceutical dosage form | |
| GB201204597D0 (en) | Topical pharmaceutical formulation | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| GB201018773D0 (en) | Topical pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |